Cargando…

Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response

A functional Human immunodeficiency Virus (HIV) cure has been proposed as an alternative to antiretroviral treatment for life, and therapeutic vaccines represent one of the most promising approaches. The goal of therapeutic vaccination is to augment virus-specific immune responses that have an impac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leal, Lorna, Fehér, Csaba, Richart, Valèria, Torres, Berta, García, Felipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564579/ https://www.ncbi.nlm.nih.gov/pubmed/32764508 http://dx.doi.org/10.3390/vaccines8030442

Ejemplares similares

Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome
por: Oriol-Tordera, Bruna, et al.
Publicado: (2022)

Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients
por: Fehér, Csaba, et al.
Publicado: (2019)

Pulmonary Infection Caused by Mycobacterium malmoense in a Chronic HIV-Infected Individual Participating in a Therapeutic Vaccine Trial
por: Marques, Joana Silva, et al.
Publicado: (2021)

Factors Affecting Virological Outcome When First-Line Antiretroviral Therapy Is Reintroduced After Unplanned Interruption
por: Maria, Suzy, et al.
Publicado: (2020)

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
por: Zacharopoulou, P., et al.
Publicado: (2022)

Wheat ATIs: Characteristics and Role in Human Disease
por: Geisslitz, Sabrina, et al.
Publicado: (2021)

Social uncertainty promotes signal complexity during approaches in wild chimpanzees (Pan troglodytes verus) and mangabeys (Cercocebus atys atys)
por: Grampp, Mathilde, et al.
Publicado: (2023)

Use of new resistance markers to predict virologic response to antiretrovirals
por: Wainberg, Mark A, et al.
Publicado: (2010)

Fitness Cost of Antiretroviral Drug Resistance Mutations on the pol Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure
por: Hunter, James R., et al.
Publicado: (2021)

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
por: O’Reilly, Paul G., et al.
Publicado: (2016)

Mechanisms of ATII-to-ATI Cell Differentiation during Lung Regeneration
por: Aspal, Mohit, et al.
Publicado: (2020)

Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis
por: Giamberardino, Charles D., et al.
Publicado: (2023)

Effect of the ati Gene Deletion on the Pathogenicity and Immunogenicity of the Vaccinia Virus
por: Yakubitskiy, S. N., et al.
Publicado: (2023)

Sea-ATI unravels novel vocabularies of plant active cistrome
por: Wen, Chenjin, et al.
Publicado: (2023)

Antiretroviral Drug-Resistance Mutations on the Gag Gene: Mutation Dynamics during Analytic Treatment Interruption among Individuals Experiencing Virologic Failure
por: Hunter, James R., et al.
Publicado: (2022)

Note sur la Firme A.T.I.: Alliance Technique Industrielle.
Publicado: (1959)

Difficult Airway Society guidelines for awake tracheal intubation (ATI) in adults
por: Ahmad, I., et al.
Publicado: (2019)

Wheat amylase/trypsin inhibitors (ATIs): occurrence, function and health aspects
por: Geisslitz, Sabrina, et al.
Publicado: (2022)

‘Immunization during ART and ATI for HIV-1 vaccine discovery/development’
por: Stamatatos, Leonidas
Publicado: (2023)

The Immunological and Virological Consequences of Planned Treatment Interruptions in Children with HIV Infection
por: Klein, Nigel, et al.
Publicado: (2013)

3α-Hydroxy-ent-atis-16-en-14-one
por: Wang, Huan, et al.
Publicado: (2009)

Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
por: Sáez-Cirión, Asier, et al.
Publicado: (2013)

Laboratory surrogate markers of residual HIV replication among distinct groups of individuals under antiretroviral therapy
por: Giron, Leila Bertoni, et al.
Publicado: (2019)

Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B
por: Rosás-Umbert, Miriam, et al.
Publicado: (2017)

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
por: Abdissa, Alemseged, et al.
Publicado: (2014)

EHMTI-0398. Long term safety of the ATI neurostimulation system for the treatment of cluster headache
por: Hillerup, S, et al.
Publicado: (2014)

Bayesian Phylogeography and Pathogenic Characterization of Smallpox Based on HA, ATI, and CrmB Genes
por: Adam, Dillon C, et al.
Publicado: (2018)

605. Efficacy and pharmacokinetics-pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis
por: Giamberardino, Charles D, et al.
Publicado: (2022)

Pregnancy and Virologic Response to Antiretroviral Therapy in South Africa
por: Westreich, Daniel, et al.
Publicado: (2011)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq, Gueorgui, et al.
Publicado: (2018)

Predictors of SIV recrudescence following antiretroviral treatment interruption
por: Pinkevych, Mykola, et al.
Publicado: (2019)

Characteristics and Outcomes of Initial Virologic Suppressors during Analytic Treatment Interruption in a Therapeutic HIV-1 gag Vaccine Trial
por: Li, Jonathan Z., et al.
Publicado: (2012)

Surrogate Adiposity Markers and Mortality
por: Khan, Irfan, et al.
Publicado: (2023)

Hard-Object Feeding in Sooty Mangabeys (Cercocebus atys) and Interpretation of Early Hominin Feeding Ecology
por: Daegling, David J., et al.
Publicado: (2011)

Genomic and experimental evidence that ALK(ATI) does not predict single agent sensitivity to ALK inhibitors
por: Inam, Haider, et al.
Publicado: (2021)

On the formation of superoxide radicals on colloidal ATiO(3) (A = Sr and Ba) nanocrystal surfaces
por: Abdullah, Muhammad, et al.
Publicado: (2020)

Kinetics and Determining Factors of the Virologic Response to Antiretrovirals during Pregnancy
por: Weinberg, Adriana, et al.
Publicado: (2009)

Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2016)

Predicting virological decay in patients starting combination antiretroviral therapy
Publicado: (2016)

EFFICACY AND SAFETY OF LOW DOSE COLCHICINE ON SURROGATE MARKERS OF CARDIOVASCULAR EVENTS IN PEOPLE LIVING WITH HIV RECEIVING ANTIRETROVIRAL THERAPY
por: Korkerdsup, Theerawat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ekadon24jf04jfqvko83fd9abl